Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Consolidated Net Income fell 209.01% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 312.10%. This contributed to the annual value of -$554,000 for FY2024, which is 93.68% up from last year.
  • Rockwell Medical's Consolidated Net Income amounted to -$1.8 million in Q3 2025, which was down 16.58% from -$1.6 million recorded in Q2 2025.
  • Rockwell Medical's Consolidated Net Income's 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of -$8.9 million in Q4 2021.
  • Moreover, its 3-year median value for Consolidated Net Income was -$1.6 million (2023), whereas its average is -$1.3 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first spiked by 179.54% in 2024, then tumbled by 632.88% in 2025.
  • Over the past 5 years, Rockwell Medical's Consolidated Net Income (Quarterly) stood at -$8.9 million in 2021, then soared by 73.59% to -$2.4 million in 2022, then soared by 31.71% to -$1.6 million in 2023, then soared by 51.70% to -$779,000 in 2024, then crashed by 209.01% to -$1.8 million in 2025.
  • Its Consolidated Net Income stands at -$1.8 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$1.6 million for Q1 2025.